Tilsotolimod
Tilsotolimod Uses, Dosage, Side Effects, Food Interaction and all others data.
Tilsotolimod is under investigation in clinical trial NCT03865082 (Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)).
Trade Name | Tilsotolimod |
Generic | Tilsotolimod |
Tilsotolimod Other Names | Tilsotolimod |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Tilsotolimod